デフォルト表紙
市場調査レポート
商品コード
1239488

内視鏡用流体管理市場:製品別、用途別、エンドユーザー別:世界の機会分析と産業予測、2021-2031年

Endoscopy Fluid Management Market By Product, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日: | 発行: Allied Market Research | ページ情報: 英文 399 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
内視鏡用流体管理市場:製品別、用途別、エンドユーザー別:世界の機会分析と産業予測、2021-2031年
出版日: 2023年01月01日
発行: Allied Market Research
ページ情報: 英文 399 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

内視鏡用流体管理市場は、2021年に6億4,064万米ドルと評価され、2022年から2031年にかけて7.2%のCAGRを示し、2031年には12億8,640万米ドルに達すると予測されています。

内視鏡用流体管理システムは、内視鏡処置中の視認性を高めるために使用される医療機器と定義されます。内腔に液圧を与え、手術領域を拡張し、破片や血液を洗浄することで作用します。内視鏡手術の中には、灌流液を使用するものもあります。内視鏡検査は、適切な診断や病気の発見のために実施される処置です。内視鏡用流体管理システムは、腹腔鏡、子宮鏡、関節鏡、泌尿器など、さまざまな内視鏡外科手術に広く使用されています。

内視鏡用流体管理システム市場の成長は、さまざまな内視鏡用流体管理システム機器の開拓のための技術進歩、腹腔鏡手術の件数の増加、最小侵襲手術の需要の急増によってもたらされます。また、胃食道逆流症(GERD)を患う人の増加も、内視鏡用流体管理システムの需要を高め、市場の成長を促進すると予想されています。Annals of Esophagus誌によると、2022年には、毎年約6000万から7000万人のアメリカ人が胃腸の病気と診断されたと報告されています。胃食道逆流症(GERD)は、最も一般的に診断される消化器疾患の1つです。したがって、GERD、関節疾患、異常子宮出血に苦しむ人口の増加は、内視鏡検査の手順の需要を増加させることに起因しています。このため、内視鏡検査用流体管理システムのニーズが高まっています。BMC Women's Health誌によると、2020年には、生殖年齢にある女性の約10%から30%が子宮異常出血と診断されたと報告されています。

例えば、2021年1月、革新的な医療技術企業であるホロジック社は、欧州で流体管理システムを発売することを発表しました。この製品は、子宮鏡下手術を行う医師に対して、より効果的な流体管理を提供するために設計されています。このように、新興国では高度な流体管理製品の市場開拓が進んでおり、市場の成長を促進することが期待されます。また、効果的な治療のための疾病の早期診断に対する需要の高まりは、世界市場拡大の主要な推進力となっています。

さらに、可処分所得の増加、高度な流体管理システム機器を製造する主要企業の増加は、内視鏡用流体管理市場の成長を促進する有利な成長機会を生み出すと期待されています。また、老年人口は関節疾患に罹患しやすいと言われています。したがって、老年人口の増加、関節症処置の必要性の急増は、さらに内視鏡用流体管理システムの需要を煽っています。例えば、EclinicalMedicineによると、2020年には、40歳以上の成人の約22%が変形性膝関節症であると報告されています。

さらに、ヘルスケアインフラを整備するための政府による支出の増加が、市場の成長を後押ししています。例えば、2022年10月、米国農務省(USDA)の農村開発は、米国バージニア州の農村部に住む人々の食糧流通や医療インフラへのアクセスを向上させるために約246万米ドルを投資しています。また、政府は国内の医療インフラの近代化と改善、医療の質の向上に投資すると思われます。さらに、政府は医療研究を支援するための追加資金を提供し、医学部や教育病院への財政支援を行う予定です。したがって、世界のヘルスケア支出の増加は、内視鏡用流体管理システムの需要を促進し、市場の成長を後押しすると予想されます。

しかし、内視鏡用流体管理システムに関連する高コストや、吐き気、腹部不快感、脱水などの流体管理システムの使用に関連する副作用が、市場成長の妨げになると予想されています。現代人は健康に対する意識が高く、その結果、健康状態を維持することを余儀なくされ、診断機器に対する需要が高まっています。このような背景から、多くの主要企業が新興国市場に参入し、店頭検査市場に有利な成長機会を提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な影響要因
    • 主な投資ポケット
  • ポーターのファイブフォース分析
    • 供給企業の交渉力
    • 買い手の交渉力
    • 代替品の脅威
    • 新規参入業者の脅威
    • 適度な競争の激しさ
  • 市場力学
    • 促進要因
      • 低侵襲手術の需要の増加
      • 内視鏡検査を必要とする慢性疾患の有病率の増加
      • 医療機器業界における研究開発活動の高度化
    • 抑制要因
      • 内視鏡手術の費用が高い
    • 機会
      • 内視鏡輸液管理システムの主要メーカーの増加
  • 市場におけるCOVID-19影響分析

第4章 内視鏡用流体管理市場:製品別

  • 概要
    • 市場規模と予測
  • 内視鏡用流体管理システム
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測:地域別
    • 市場シェア分析: 国別
  • 内視鏡用流体管理付属品
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測:地域別
    • 市場シェア分析: 国別

第5章 内視鏡用流体管理市場:用途別

  • 概要
    • 市場規模と予測
  • 腹腔鏡検査
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測:地域別
    • 市場シェア分析: 国別
  • 子宮鏡検査
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測:地域別
    • 市場シェア分析: 国別
  • その他
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測:地域別
    • 市場シェア分析: 国別

第6章 内視鏡用流体管理市場:エンドユーザー別

  • 概要
    • 市場規模と予測
  • 病院
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測:地域別
    • 市場シェア分析: 国別
  • 診療所
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測:地域別
    • 市場シェア分析: 国別
  • その他
    • 主要な市場動向、成長要因と機会
    • 市場規模と予測:地域別
    • 市場シェア分析: 国別

第7章 内視鏡用流体管理市場:地域別

  • 概要
    • 市場規模と予測:地域別
  • 北米
    • 主な動向と機会
    • 市場規模と予測:製品別
    • 市場規模と予測:用途別
    • 市場規模と予測:エンドユーザー別
    • 市場規模と予測:国別
      • 米国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測:製品別
      • 市場規模と予測:用途別
      • 市場規模と予測:エンドユーザー別
      • カナダ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測:製品別
      • 市場規模と予測:用途別
      • 市場規模と予測:エンドユーザー別
      • メキシコ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測:製品別
      • 市場規模と予測:用途別
      • 市場規模と予測:エンドユーザー別
  • 欧州
    • 主な動向と機会
    • 市場規模と予測:製品別
    • 市場規模と予測:用途別
    • 市場規模と予測:エンドユーザー別
    • 市場規模と予測:国別
      • ドイツ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測:製品別
      • 市場規模と予測:用途別
      • 市場規模と予測:エンドユーザー別
      • フランス
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測:製品別
      • 市場規模と予測:用途別
      • 市場規模と予測:エンドユーザー別
      • 英国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測:製品別
      • 市場規模と予測:用途別
      • 市場規模と予測:エンドユーザー別
      • イタリア
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測:製品別
      • 市場規模と予測:用途別
      • 市場規模と予測:エンドユーザー別
      • スペイン
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測:製品別
      • 市場規模と予測:用途別
      • 市場規模と予測:エンドユーザー別
      • その他欧州
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測:製品別
      • 市場規模と予測:用途別
      • 市場規模と予測:エンドユーザー別
  • アジア太平洋
    • 主な動向と機会
    • 市場規模と予測:製品別
    • 市場規模と予測:用途別
    • 市場規模と予測:エンドユーザー別
    • 市場規模と予測:国別
      • 日本
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測:製品別
      • 市場規模と予測:用途別
      • 市場規模と予測:エンドユーザー別
      • 中国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測:製品別
      • 市場規模と予測:用途別
      • 市場規模と予測:エンドユーザー別
      • インド
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測:製品別
      • 市場規模と予測:用途別
      • 市場規模と予測:エンドユーザー別
      • オーストラリア
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測:製品別
      • 市場規模と予測:用途別
      • 市場規模と予測:エンドユーザー別
      • 韓国
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測:製品別
      • 市場規模と予測:用途別
      • 市場規模と予測:エンドユーザー別
      • その他アジア太平洋地域
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測:製品別
      • 市場規模と予測:用途別
      • 市場規模と予測:エンドユーザー別
  • ラテンアメリカ・中東・アフリカ
    • 主な動向と機会
    • 市場規模と予測:製品別
    • 市場規模と予測:用途別
    • 市場規模と予測:エンドユーザー別
    • 市場規模と予測:国別
      • ブラジル
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測:製品別
      • 市場規模と予測:用途別
      • 市場規模と予測:エンドユーザー別
      • サウジアラビア
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測:製品別
      • 市場規模と予測:用途別
      • 市場規模と予測:エンドユーザー別
      • 南アフリカ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測:製品別
      • 市場規模と予測:用途別
      • 市場規模と予測:エンドユーザー別
      • その他のラテンアメリカ・中東・アフリカ
      • 主要な市場動向、成長要因と機会
      • 市場規模と予測:製品別
      • 市場規模と予測:用途別
      • 市場規模と予測:エンドユーザー別

第8章 競合情勢

  • イントロダクション
  • 主要成功戦略
  • トップ 10プレーヤーの製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • トッププレーヤーのポジショニング、2021

第9章 企業プロファイル

  • Medtronic plc
  • Olympus america inc
  • KARL STORZ SE & Co. KG
  • Stryker Corporation
  • Hologic Inc.
  • Arthrex, Inc.
  • CONMED Corporation
  • COMEG medical technologies
  • STERIS plc
  • B. Braun SE
図表

LIST OF TABLES

  • TABLE 01. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 02. ENDOSCOPY FLUID MANAGEMENT MARKET FOR ENDOSCOPY FLUID MANAGEMENT SYSTEM, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 03. ENDOSCOPY FLUID MANAGEMENT MARKET FOR ENDOSCOPY FLUID MANAGEMENT ACCESSORIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 04. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 05. ENDOSCOPY FLUID MANAGEMENT MARKET FOR LAPAROSCOPY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 06. ENDOSCOPY FLUID MANAGEMENT MARKET FOR HYSTEROSCOPY, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 07. ENDOSCOPY FLUID MANAGEMENT MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 08. GLOBAL ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 09. ENDOSCOPY FLUID MANAGEMENT MARKET FOR HOSPITAL, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. ENDOSCOPY FLUID MANAGEMENT MARKET FOR CLINICS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. ENDOSCOPY FLUID MANAGEMENT MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. ENDOSCOPY FLUID MANAGEMENT MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. NORTH AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. NORTH AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. NORTH AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. NORTH AMERICA ENDOSCOPY FLUID MANAGEMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. U.S. ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. U.S. ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. U.S. ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. CANADA ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. CANADA ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. CANADA ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. MEXICO ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. MEXICO ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. MEXICO ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. GERMANY ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. GERMANY ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. GERMANY ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. FRANCE ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. FRANCE ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. FRANCE ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. UK ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. UK ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. UK ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. ITALY ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. ITALY ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. ITALY ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. SPAIN ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. SPAIN ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. SPAIN ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. REST OF EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. REST OF EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. REST OF EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. JAPAN ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. JAPAN ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. JAPAN ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. CHINA ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. CHINA ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. CHINA ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. INDIA ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. INDIA ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. INDIA ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. AUSTRALIA ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. AUSTRALIA ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. AUSTRALIA ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. SOUTH KOREA ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. SOUTH KOREA ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. SOUTH KOREA ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. REST OF ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. LAMEA ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. LAMEA ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. LAMEA ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. LAMEA ENDOSCOPY FLUID MANAGEMENT MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. BRAZIL ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. BRAZIL ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. BRAZIL ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. SAUDI ARABIA ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. SAUDI ARABIA ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. SAUDI ARABIA ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. SOUTH AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. SOUTH AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. SOUTH AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. REST OF LAMEA ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. REST OF LAMEA ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. REST OF LAMEA ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 87. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 88. MEDTRONIC PLC: PRODUCT SEGMENTS
  • TABLE 89. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 90. OLYMPUS AMERICA INC: KEY EXECUTIVES
  • TABLE 91. OLYMPUS AMERICA INC: COMPANY SNAPSHOT
  • TABLE 92. OLYMPUS AMERICA INC: PRODUCT SEGMENTS
  • TABLE 93. OLYMPUS AMERICA INC: PRODUCT PORTFOLIO
  • TABLE 94. KARL STORZ SE & CO. KG: KEY EXECUTIVES
  • TABLE 95. KARL STORZ SE & CO. KG: COMPANY SNAPSHOT
  • TABLE 96. KARL STORZ SE & CO. KG: PRODUCT SEGMENTS
  • TABLE 97. KARL STORZ SE & CO. KG: PRODUCT PORTFOLIO
  • TABLE 98. STRYKER CORPORATION: KEY EXECUTIVES
  • TABLE 99. STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 100. STRYKER CORPORATION: PRODUCT SEGMENTS
  • TABLE 101. STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 102. HOLOGIC INC.: KEY EXECUTIVES
  • TABLE 103. HOLOGIC INC.: COMPANY SNAPSHOT
  • TABLE 104. HOLOGIC INC.: PRODUCT SEGMENTS
  • TABLE 105. HOLOGIC INC.: PRODUCT PORTFOLIO
  • TABLE 106. HOLOGIC INC.: KEY STRATERGIES
  • TABLE 107. ARTHREX, INC.: KEY EXECUTIVES
  • TABLE 108. ARTHREX, INC.: COMPANY SNAPSHOT
  • TABLE 109. ARTHREX, INC.: PRODUCT SEGMENTS
  • TABLE 110. ARTHREX, INC.: PRODUCT PORTFOLIO
  • TABLE 111. CONMED CORPORATION: KEY EXECUTIVES
  • TABLE 112. CONMED CORPORATION: COMPANY SNAPSHOT
  • TABLE 113. CONMED CORPORATION: PRODUCT SEGMENTS
  • TABLE 114. CONMED CORPORATION: PRODUCT PORTFOLIO
  • TABLE 115. COMEG MEDICAL TECHNOLOGIES: KEY EXECUTIVES
  • TABLE 116. COMEG MEDICAL TECHNOLOGIES: COMPANY SNAPSHOT
  • TABLE 117. COMEG MEDICAL TECHNOLOGIES: PRODUCT SEGMENTS
  • TABLE 118. COMEG MEDICAL TECHNOLOGIES: PRODUCT PORTFOLIO
  • TABLE 119. STERIS PLC: KEY EXECUTIVES
  • TABLE 120. STERIS PLC: COMPANY SNAPSHOT
  • TABLE 121. STERIS PLC: PRODUCT SEGMENTS
  • TABLE 122. STERIS PLC: PRODUCT PORTFOLIO
  • TABLE 123. B. BRAUN SE: KEY EXECUTIVES
  • TABLE 124. B. BRAUN SE: COMPANY SNAPSHOT
  • TABLE 125. B. BRAUN SE: PRODUCT SEGMENTS
  • TABLE 126. B. BRAUN SE: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031
  • FIGURE 02. SEGMENTATION OF ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031
  • FIGURE 03. TOP INVESTMENT POCKETS IN ENDOSCOPY FLUID MANAGEMENT MARKET (2022-2031)
  • FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 06. MODERATE THREAT OF SUBSTITUTES
  • FIGURE 07. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 08. MODERATE INTENSITY OF RIVALRY
  • FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALENDOSCOPY FLUID MANAGEMENT MARKET
  • FIGURE 10. ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT, 2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF ENDOSCOPY FLUID MANAGEMENT MARKET FOR ENDOSCOPY FLUID MANAGEMENT SYSTEM, BY COUNTRY 2021-2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF ENDOSCOPY FLUID MANAGEMENT MARKET FOR ENDOSCOPY FLUID MANAGEMENT ACCESSORIES, BY COUNTRY 2021-2031(%)
  • FIGURE 13. ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION, 2021(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF ENDOSCOPY FLUID MANAGEMENT MARKET FOR LAPAROSCOPY, BY COUNTRY 2021-2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF ENDOSCOPY FLUID MANAGEMENT MARKET FOR HYSTEROSCOPY, BY COUNTRY 2021-2031(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF ENDOSCOPY FLUID MANAGEMENT MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 17. ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER, 2021(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF ENDOSCOPY FLUID MANAGEMENT MARKET FOR HOSPITAL, BY COUNTRY 2021-2031(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF ENDOSCOPY FLUID MANAGEMENT MARKET FOR CLINICS, BY COUNTRY 2021-2031(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF ENDOSCOPY FLUID MANAGEMENT MARKET FOR OTHERS, BY COUNTRY 2021-2031(%)
  • FIGURE 21. ENDOSCOPY FLUID MANAGEMENT MARKET BY REGION, 2021
  • FIGURE 22. U.S. ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 23. CANADA ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 24. MEXICO ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 25. GERMANY ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 26. FRANCE ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 27. UK ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 28. ITALY ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 29. SPAIN ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 30. REST OF EUROPE ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 31. JAPAN ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 32. CHINA ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 33. INDIA ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 34. AUSTRALIA ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 35. SOUTH KOREA ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 36. REST OF ASIA-PACIFIC ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 37. BRAZIL ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 38. SAUDI ARABIA ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 39. SOUTH AFRICA ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 40. REST OF LAMEA ENDOSCOPY FLUID MANAGEMENT MARKET, 2021-2031 ($MILLION)
  • FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 44. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 45. COMPETITIVE DASHBOARD
  • FIGURE 46. COMPETITIVE HEATMAP: ENDOSCOPY FLUID MANAGEMENT MARKET
  • FIGURE 47. TOP PLAYER POSITIONING, 2021
  • FIGURE 48. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 50. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 51. OLYMPUS AMERICA INC: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 52. OLYMPUS AMERICA INC: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 53. OLYMPUS AMERICA INC: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 54. STRYKER CORPORATION: NET REVENUE, 2019-2021 ($MILLION)
  • FIGURE 55. STRYKER CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 56. STRYKER CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 57. HOLOGIC INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 58. HOLOGIC INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 59. HOLOGIC INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 60. CONMED CORPORATION: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 61. CONMED CORPORATION: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 62. CONMED CORPORATION: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 63. STERIS PLC: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 64. STERIS PLC: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 65. STERIS PLC: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 66. B. BRAUN SE: NET SALES, 2019-2021 ($MILLION)
  • FIGURE 67. B. BRAUN SE: REVENUE SHARE BY SEGMENT, 2021 (%)
  • FIGURE 68. B. BRAUN SE: REVENUE SHARE BY REGION, 2021 (%)
目次
Product Code: A10966

The Endoscopy Fluid Management Market valued for $640.64 million in 2021 and is estimated to reach $1,286.4 million by 2031, exhibiting a CAGR of 7.2% from 2022 to 2031. The endoscopic fluid management system is defined as the medical device which is used to enhance visibility during endoscopic procedure. It acts by providing fluid pressure to the internal cavities, dilating the operating area, and washing the debris and blood. Some of the endoscopic surgical procedures involve the use of irrigating fluids. Endoscopy is a procedure which is conducted for proper diagnosis, and detection of disease. Endoscopy fluid management system is widely used for various endoscopic surgical procedure such as laparoscopy, hysteroscopy, arthroscopy, and urology.

The growth of endoscopy fluid management market is driven by technological advancement for development of different endoscopy fluid management systems devices, rise in the number of laparoscopy procedures, and surge in demand for minimal invasive surgical procedure. In addition, rise in the number of people suffering from gastroesophageal reflux disease (GERD) is anticipated to fuel the demand for endoscopy fluid management systems and drive the growth of market. According to the Journal of Annals of Esophagus, in 2022, around 60 to 70 million American population were reported to have been diagnosed with gastrointestinal disease, every year. Gastroesophageal reflux disease (GERD) is one of the most commonly diagnosed gastrointestinal disease. Thus, rise in population suffering from GERD, joint disease, and abnormal uterine bleeding is attributed to increase the demand for endoscopy procedure. This boosts the need of endoscopy fluid management system. According to the Journal of BMC Women's Health, in 2020, approximately 10% to 30% of women in reproductive age were reported to have been diagnosed with abnormal uterine bleeding.

For instance, in January 2021, the Hologic, Inc., an innovative medical technology company, announced the launch of fluent fluid management system, in Europe. This product is designed to offers more effective fluid management for physician in hysteroscopic procedures. Thus, increase in development of advanced fluid management products in emerging nations are expected to propel the growth of the market. In addition, the rise in demand for early diagnosis of disease for effective treatment acts a key driving force for the expansion of the global market.

Moreover, increase in disposable income, and rise in number of key players to manufacturer advanced fluid management system devices are expected to create lucrative growth opportunities to drive the growth of the endoscopy fluid management market. In addition, geriatric population is susceptible to joint diseases. Thus, rise in number of geriatric population, surge in need for arthropathy procedure, which further fuel the demand for endoscopic fluid management system. For instance, according to EclinicalMedicine, in 2020, it was reported that around 22% of adult above the age of 40 years have knee osteoarthritis.

Furthermore, rise in expenditure by government to develop healthcare infrastructure fuels the market growth. For instance, in October 2022, U.S. Department of Agriculture (USDA) rural development invests around $2.46 million to increase access to food distribution and healthcare infrastructure for population living in rural Virginia, U.S. In addition, the government is likely to invest in modernizing and improving the nation's healthcare infrastructure, and improve the quality of care. Furthermore, the government is likely to invest in providing additional funding to support medical research, and providing financial support for medical schools and teaching hospitals. Hence, rise in healthcare expenditure across the globe is expected to fuel the demand for endoscopy fluid management system, thereby boosting the market growth.

However, high cost associated with endoscopic fluid management systems and side effect associated with the use of fluid management system such as nausea, abdominal discomfort, and dehydration are anticipated to hinder the market growth. Now-a-day, population are aware of health, which in turn is compelling them to maintain their health condition and increase the demand for diagnosis devices. This has further encouraged many key players to enter emerging markets, thus offering a lucrative growth opportunity in the over-the-counter tests market.

The global endoscopy fluid management system market is segmented into product, application, and end user. On the basis of product, the market is divided into endoscopy fluid management system, and endoscopy fluid management accessories. On the basis of application, the market is divided into laparoscopy, hysteroscopy, and others. The others include arthroscopy, and urology. On the basis of end user, the market is divided into hospitals, clinics and others. The others segment includes ambulatory surgical center, physician practices, diagnostic centers. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global medical exoskeleton market include: Medtronic, Olympus America, Karl Storz Se & Co. Kg, Stryker, Hologic Inc, Arthrex, Inc, B. Braun, Cantel, COMEG, and CONMED Corporation

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the endoscopy fluid management market analysis from 2021 to 2031 to identify the prevailing endoscopy fluid management market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the endoscopy fluid management market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global endoscopy fluid management market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Endoscopy fluid management system
  • Endoscopy fluid management accessories

By Application

  • Laparoscopy
  • Hysteroscopy
  • Others

By End User

  • Hospital
  • Clinics
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players

  • Medtronic plc
  • STERIS plc
  • KARL STORZ SE & Co. KG
  • Arthrex, Inc.
  • B. Braun SE
  • Stryker Corporation
  • Hologic Inc.
  • CONMED Corporation
  • Olympus america inc
  • COMEG medical technologies

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate bargaining power of buyers
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate threat of new entrants
    • 3.3.5. Moderate intensity of rivalry
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Increase in the demand for minimally invasive surgeries
      • 3.4.1.2. Increase in the prevalence of chronic disease that require endoscopy procedure
      • 3.4.1.3. Advancement in R&D activities in medical device industry
    • 3.4.2. Restraints
      • 3.4.2.1. High cost of endoscopic procedure
    • 3.4.3. Opportunities
      • 3.4.3.1. Increase in the number of key players to manufacture endoscopic fluid management systems
  • 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: ENDOSCOPY FLUID MANAGEMENT MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Endoscopy fluid management system
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Endoscopy fluid management accessories
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: ENDOSCOPY FLUID MANAGEMENT MARKET, BY APPLICATION

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Laparoscopy
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Hysteroscopy
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: ENDOSCOPY FLUID MANAGEMENT MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Hospital
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Clinics
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: ENDOSCOPY FLUID MANAGEMENT MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key trends and opportunities
    • 7.2.2. Market size and forecast, by Product
    • 7.2.3. Market size and forecast, by Application
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Key market trends, growth factors and opportunities
      • 7.2.5.1.2. Market size and forecast, by Product
      • 7.2.5.1.3. Market size and forecast, by Application
      • 7.2.5.1.4. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Key market trends, growth factors and opportunities
      • 7.2.5.2.2. Market size and forecast, by Product
      • 7.2.5.2.3. Market size and forecast, by Application
      • 7.2.5.2.4. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Key market trends, growth factors and opportunities
      • 7.2.5.3.2. Market size and forecast, by Product
      • 7.2.5.3.3. Market size and forecast, by Application
      • 7.2.5.3.4. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key trends and opportunities
    • 7.3.2. Market size and forecast, by Product
    • 7.3.3. Market size and forecast, by Application
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Key market trends, growth factors and opportunities
      • 7.3.5.1.2. Market size and forecast, by Product
      • 7.3.5.1.3. Market size and forecast, by Application
      • 7.3.5.1.4. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Key market trends, growth factors and opportunities
      • 7.3.5.2.2. Market size and forecast, by Product
      • 7.3.5.2.3. Market size and forecast, by Application
      • 7.3.5.2.4. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Key market trends, growth factors and opportunities
      • 7.3.5.3.2. Market size and forecast, by Product
      • 7.3.5.3.3. Market size and forecast, by Application
      • 7.3.5.3.4. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Key market trends, growth factors and opportunities
      • 7.3.5.4.2. Market size and forecast, by Product
      • 7.3.5.4.3. Market size and forecast, by Application
      • 7.3.5.4.4. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Key market trends, growth factors and opportunities
      • 7.3.5.5.2. Market size and forecast, by Product
      • 7.3.5.5.3. Market size and forecast, by Application
      • 7.3.5.5.4. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Key market trends, growth factors and opportunities
      • 7.3.5.6.2. Market size and forecast, by Product
      • 7.3.5.6.3. Market size and forecast, by Application
      • 7.3.5.6.4. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key trends and opportunities
    • 7.4.2. Market size and forecast, by Product
    • 7.4.3. Market size and forecast, by Application
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Key market trends, growth factors and opportunities
      • 7.4.5.1.2. Market size and forecast, by Product
      • 7.4.5.1.3. Market size and forecast, by Application
      • 7.4.5.1.4. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Key market trends, growth factors and opportunities
      • 7.4.5.2.2. Market size and forecast, by Product
      • 7.4.5.2.3. Market size and forecast, by Application
      • 7.4.5.2.4. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Key market trends, growth factors and opportunities
      • 7.4.5.3.2. Market size and forecast, by Product
      • 7.4.5.3.3. Market size and forecast, by Application
      • 7.4.5.3.4. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Key market trends, growth factors and opportunities
      • 7.4.5.4.2. Market size and forecast, by Product
      • 7.4.5.4.3. Market size and forecast, by Application
      • 7.4.5.4.4. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Key market trends, growth factors and opportunities
      • 7.4.5.5.2. Market size and forecast, by Product
      • 7.4.5.5.3. Market size and forecast, by Application
      • 7.4.5.5.4. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Key market trends, growth factors and opportunities
      • 7.4.5.6.2. Market size and forecast, by Product
      • 7.4.5.6.3. Market size and forecast, by Application
      • 7.4.5.6.4. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key trends and opportunities
    • 7.5.2. Market size and forecast, by Product
    • 7.5.3. Market size and forecast, by Application
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Key market trends, growth factors and opportunities
      • 7.5.5.1.2. Market size and forecast, by Product
      • 7.5.5.1.3. Market size and forecast, by Application
      • 7.5.5.1.4. Market size and forecast, by End User
      • 7.5.5.2. Saudi Arabia
      • 7.5.5.2.1. Key market trends, growth factors and opportunities
      • 7.5.5.2.2. Market size and forecast, by Product
      • 7.5.5.2.3. Market size and forecast, by Application
      • 7.5.5.2.4. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Key market trends, growth factors and opportunities
      • 7.5.5.3.2. Market size and forecast, by Product
      • 7.5.5.3.3. Market size and forecast, by Application
      • 7.5.5.3.4. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Key market trends, growth factors and opportunities
      • 7.5.5.4.2. Market size and forecast, by Product
      • 7.5.5.4.3. Market size and forecast, by Application
      • 7.5.5.4.4. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

  • 9.1. Medtronic plc
    • 9.1.1. Company overview
    • 9.1.2. Key Executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
  • 9.2. Olympus america inc
    • 9.2.1. Company overview
    • 9.2.2. Key Executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
  • 9.3. KARL STORZ SE & Co. KG
    • 9.3.1. Company overview
    • 9.3.2. Key Executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
  • 9.4. Stryker Corporation
    • 9.4.1. Company overview
    • 9.4.2. Key Executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
  • 9.5. Hologic Inc.
    • 9.5.1. Company overview
    • 9.5.2. Key Executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
    • 9.5.7. Key strategic moves and developments
  • 9.6. Arthrex, Inc.
    • 9.6.1. Company overview
    • 9.6.2. Key Executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
  • 9.7. CONMED Corporation
    • 9.7.1. Company overview
    • 9.7.2. Key Executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
  • 9.8. COMEG medical technologies
    • 9.8.1. Company overview
    • 9.8.2. Key Executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
  • 9.9. STERIS plc
    • 9.9.1. Company overview
    • 9.9.2. Key Executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
  • 9.10. B. Braun SE
    • 9.10.1. Company overview
    • 9.10.2. Key Executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance